The report "Cell-free Protein Synthesis Market by Offering (Cell Extract Systems (Prokaryotic, Mammalian, Plant), Kits, Instruments, Services), Workflow, Method (Coupled TX/TL, Transcription, Translation), Application (Protein Purification) - Global Forecast to 2030", is expected to reach USD 308.9 million by 2030, up from USD 217.2 million in 2025, at a CAGR of 7.3% during the forecast period.

Browse 400 market data Tables and 45 Figures spread through 300 Pages and in-depth TOC on "Cell-free Protein Synthesis Market by Offering (Cell Extract Systems (Prokaryotic, Mammalian, Plant), Kits, Instruments, Services), Workflow, Method (Coupled TX/TL, Transcription, Translation), Application (Protein Purification) - Global Forecast to 2030"

Download PDF - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=141393235

The cell-free protein synthesis market is experiencing strong growth, driven by increasing demand for faster and more adaptable protein production technologies across research, drug discovery, and biotechnology fields. CFPS's ability to efficiently produce toxic and hard-to-express proteins, along with its integration into synthetic biology, enzyme engineering, and vaccine development, is opening new opportunities for adoption. Its growing use in antibody prototyping, personalized therapeutics, and biosensor development further emphasizes its potential in precision medicine and translational research. Additionally, rising R&D investments by pharmaceutical and biotech companies, combined with government funding to accelerate life sciences innovation, are fueling market growth. With ongoing innovation, the adoption of reconstituted systems, and the integration of AI/ML for optimization, the cell-free protein synthesis market is poised for sustained strong growth in the coming years.

Cell-free protein synthesis services are projected to register the fastest growth in the market by offering during the forecast period.”

Based on offerings, the cell-free protein synthesis market is divided into products (such as expression systems, reagents, and instruments) and services. CFPS services are expected to grow the fastest in the CFPS market during the forecast period, due to their ability to deliver customized protein expression, lower infrastructure and operational costs for users, and support high-throughput research and drug discovery projects. The demand for services is also increasing because more pharmaceutical and biotechnology companies, academic researchers, and diagnostic developers are outsourcing, relying on specialized providers for quick turnaround, technical expertise, and scalable production. This trend is further supported by the need for flexible, project-based solutions that give clients access to advanced CFPS technologies without the burden of maintaining in-house capabilities.

In 2024, the coupled transcription–translation (Tx/Tl) expression method accounted for the largest share of the cell-free protein synthesis market.

The cell-free protein synthesis market is categorized by method into coupled transcription–translation (Tx/Tl) and translation-only expression approaches. In 2024, coupled transcription–translation (Tx/Tl) held the largest market share because of its ability to streamline protein production by combining transcription and translation in one reaction. This method greatly cuts down on time and labor, allowing for quick protein synthesis directly from DNA templates. The Tx/Tl technique is favored for its high efficiency, versatility in producing various proteins, and suitability for high-throughput applications like enzyme engineering, pathway prototyping, and therapeutic development. Its adaptability to both prokaryotic and eukaryotic systems also makes it appealing for research, diagnostics, and industrial biotech, fueling its leading position in the CFPS market.

The North America region held the largest share of the cell-free protein synthesis market in 2024.

The market for cell-free protein synthesis is categorized by regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2024, North America dominated the global market, driven by its strong research infrastructure, high biotech investments, presence of leading CFPS firms, and widespread use of advanced protein synthesis methods across academic, pharmaceutical, and industrial fields. Meanwhile, Asia-Pacific is projected to experience the fastest growth, aided by increasing government funding for biotech and life sciences, rapid development in pharmaceutical and synthetic biology sectors, and the expanding use of cell-free protein synthesis in both research and industry. Countries like China, Japan, South Korea, and India are heavily investing in R&D and infrastructure, attracting international companies and opening up substantial opportunities for market growth.

Key players in the cell-free protein synthesis market include Promega Corporation (US), New England Biolabs (US), Thermo Fisher Scientific Inc. (US), Takara Bio (Japan), and Genscript (US), among others.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.